A7378112
Sumatriptan Succinate , ≥98%(HPLC) , 103628-48-4
Synonym(s):
3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide succinate;GR-43175;Sumatriptan succinate
CAS NO.：103628-48-4
Empirical Formula: C18H27N3O6S
Molecular Weight: 413.488
MDL number: MFCD00866222
EINECS: 600-463-4
| Pack Size | Price | Stock | Quantity |
| 50MG | RMB119.20 | In Stock |
|
| 250MG | RMB302.40 | In Stock |
|
| 100mg | RMB479.20 | In Stock |
|
| 1G | RMB2272.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 165-166°C |
| storage temp. | -20°C |
| solubility | H2O: >20mg/mL |
| form | solid |
| color | white to off-white |
| Merck | 14,8997 |
| BCS Class | 3 |
| InChIKey | PORMUFZNYQJOEI-UHFFFAOYSA-N |
Description and Uses
Sumatriptan succinate is a highly selective 5HT1-like receptor agonist introduced as a new treatment for migraine. It is indicated for the acute relief of migraine and cluster headache. Oral administration is reported to be free of substantial side effects. The compound appears to be a significant advance over the use of ergotamine and other agents in the treatment of migraine.
Sumatriptan Succinate is a selective 5-HT1B/1D-receptor agonist with anticonvulsant properties (1,2). Sumatriptan Succinate is used for migraine relief (2).
Safety
| Symbol(GHS) |  GHS08 |
| Signal word | Warning |
| Hazard statements | H361d-H412 |
| Precautionary statements | P202-P273-P280-P308+P313-P405-P501 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38-41 |
| Safety Statements | 26-36-39 |
| RIDADR | 3077 |
| WGK Germany | 3 |
| RTECS | EJ9940000 |
| HS Code | 29350090 |
